These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19297359)

  • 1. The correlation between dental calculus and disturbed mineral metabolism in paediatric patients with chronic kidney disease.
    Davidovich E; Davidovits M; Peretz B; Shapira J; Aframian DJ
    Nephrol Dial Transplant; 2009 Aug; 24(8):2439-45. PubMed ID: 19297359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated salivary potassium in paediatric CKD patients, a novel excretion pathway.
    Davidovich E; Davidovits M; Peretz B; Shapira J; Aframian DJ
    Nephrol Dial Transplant; 2011 May; 26(5):1541-6. PubMed ID: 20921301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
    Savica V; Calò LA; Granata A; Caldarera R; Cavaleri A; Santoro D; Monardo P; Savica R; Muraca U; Bellinghieri G
    Clin Nephrol; 2007 Oct; 68(4):216-21. PubMed ID: 17969488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous modulators of Ca2+-Mg2+-dependent ATPase in children with chronic kidney disease (CKD).
    Polak-Jonkisz D; Purzyc L; Laszki-Szczachor K; Musial K; Zwolinska D
    Nephrol Dial Transplant; 2010 Feb; 25(2):438-44. PubMed ID: 19854852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DMF index in patients with end-stage kidney disease].
    Rojas Peña S; Mora Muñoz A; Gordillo Paniagua G; Jackson Herrerías G
    Pract Odontol; 1991 Jan; 12(1):9-11, 13. PubMed ID: 1946203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between unstimulated salivary flow rate and saliva composition of healthy children in Taiwan.
    Wu KP; Ke JY; Chung CY; Chen CL; Hwang TL; Chou MY; Wong AM; Hu CF; Lee YC
    Chang Gung Med J; 2008; 31(3):281-6. PubMed ID: 18782951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
    Michelis R; Sela S; Ben-Zvi I; Nagler RM
    Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary composition and calculus formation in patients undergoing hemodialysis.
    Epstein SR; Mandel I; Scopp IW
    J Periodontol; 1980 Jun; 51(6):336-8. PubMed ID: 6930471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification.
    Sigrist MK; Levin A; Er L; McIntyre CW
    Nephrol Dial Transplant; 2009 Oct; 24(10):3157-62. PubMed ID: 19491380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary phosphate secretion in chronic kidney disease.
    Savica V; Calò L; Santoro D; Monardo P; Granata A; Bellinghieri G
    J Ren Nutr; 2008 Jan; 18(1):87-90. PubMed ID: 18089451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of hyperphosphatemia in patients with chronic kidney disease].
    Savica V; Santoro D; Monardo P; Mallamace A; Bellinghieri G
    G Ital Nefrol; 2009; 26 Suppl 46():58-61. PubMed ID: 19644820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental calculus formation in children and adolescents undergoing hemodialysis.
    Martins C; Siqueira WL; Oliveira E; Nicolau J; Primo LG
    Pediatr Nephrol; 2012 Oct; 27(10):1961-6. PubMed ID: 22814946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease].
    Yano S
    Clin Calcium; 2007 Dec; 17(12):1870-8. PubMed ID: 18057663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial calcification in patients with chronic kidney disease.
    Koleganova N; Piecha G; Ritz E; Schirmacher P; Müller A; Meyer HP; Gross ML
    Nephrol Dial Transplant; 2009 Aug; 24(8):2488-96. PubMed ID: 19329792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in salivary composition in patients with renal failure.
    Tomás I; Marinho JS; Limeres J; Santos MJ; Araújo L; Diz P
    Arch Oral Biol; 2008 Jun; 53(6):528-32. PubMed ID: 18294611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease.
    Nikolov IG; Mozar A; Drüeke TB; Massy ZA
    Blood Purif; 2009; 27(4):350-9. PubMed ID: 19295198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of the mechanism for vascular calcification in chronic kidney disease].
    Persy V
    Verh K Acad Geneeskd Belg; 2008; 70(4):285-303. PubMed ID: 19166100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can salivary creatinine and urea levels be used to diagnose chronic kidney disease in children as accurately as serum creatinine and urea levels? A case-control study.
    Renda R
    Ren Fail; 2017 Nov; 39(1):452-457. PubMed ID: 28372505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.